Nucleic acid‐based non‐invasive prenatal diagnosis of genetic skin diseases: are we ready?
Experimental Dermatology2013Vol. 22(6), pp. 392–395
Citations Over TimeTop 14% of 2013 papers
Abstract
The discovery of circulating fetal nucleic acids is a great step on the way of developing non-invasive prenatal diagnosis (NIPD) for genetic disorders. Here, we briefly discuss the current applications of circulating fetal nucleic acids in genetic testing for different kinds of hereditary diseases with an emphasis on using circulating cell-free fetal DNA in diagnosis of monogenic disorders. As the genetic skin disorders impair the quality of life at different levels, we next discuss some ethical issues in NIPD for genetic skin diseases of various severities and in particular, the responsibility of doctors and parents, respectively, in the prenatal genetic testing.
Related Papers
- → Self Diagnosis of Lynch Syndrome Using Direct to Consumer Genetic Testing: A Case Study(2011)18 cited
- → Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic Testing(2016)24 cited
- → A Commentary on Commercial Genetic Testing and the Future of the Genetic Counseling Profession(2018)21 cited
- → Perception of genetic testing among patients with inherited retinal disease: Benefits and challenges in a Japanese population(2022)3 cited
- → Uptake of genetic testing among patients seeking cancer genetic counseling in Taiwan(2023)1 cited